Goldman Sachs Group »

Armata Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Armata Pharmaceuticals (ARMP) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Armata Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Armata Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Armata Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $284k 45k 6.28
2022-12-31 $17k 14k 1.24

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Spdr S&p 500 Etf Tr CMN (SPY)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Amazon CMN (AMZN)
Broadcom CMN (AVGO)
Meta Platforms CMN (META)
Invesco Qqq Tr CMN (QQQ)
Vanguard Index Fds CMN (VOO)
Alphabet CMN (GOOG)
Ishares Tr CMN (IVV)
Eli Lilly & Co CMN (LLY)
Jpmorgan Chase & Co. CMN (JPM)

View all positions for Goldman Sachs Group

Top funds holding Armata Pharmaceuticals

Vanguard Group
683 Capital Management
Geode Capital Management
Edgewood Management
Renaissance Technologies
State Street Corporation
Goldman Sachs Group
Bridgeway Capital Management
SeaCrest Wealth Management
GSB Wealth Management
OMERS Administration Corporation
BlackRock
Northern Trust
Susquehanna International
Qube Research & Technologies

View all funds holding Armata Pharmaceuticals